Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and remifentanil for pain control in gynecologic laparoscopic surgery
IRCT20110712007013N24Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Dec 2019
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of dexmedetomidine and remifentanil in acute postoperative pain (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Pain after gynecological laparoscopic surgery. Started Dec 2019; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
acute postoperative pain
Beyond the preview
Go deeper on IRCT20110712007013N24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110712007013N24.